Lɛ wi jɔs lan bɔt Alkylating Agents fɔ Breast Cancer

We dɔktɔ dɛn tɛl yu se yu gɛt bɔdi kansa, yu dɔktɔ kin tɛl yu fɔ tek kemotɛrapi. Na nɔmal tin fɔ mek yu fred smɔl ɛn wɔri we yu yɛri dis. Bɔt we dɛn tɛl yu fayn fayn wan bɔt dɛn tritmɛnt ya , yu go ebul fɔ lɛf da fred de. Difrɛn kayn kemotɛrapi tritmɛnt dɛn de. Alkylating agents na wan pan di men klas dɛm fɔ drɔgs we dɛn kin yuz fɔ brɔst kansa. So, lɛ wi tɔk bɔt dis ditayli ɛn rili simpul wan tide.

Aw dɛn mɛrɛsin ya we dɛn kɔl Alkylating Agents kin rili wok?

Fɔ ɔndastand dis, wi nid fɔ tink fɔs bɔt di kansa sɛl dɛn. di kεnsar sεl dεm na sεl dεm we de sheb εn de bכku kwik kwik wan we dεn nכ de kכntrכl. Alkylating agents na bin wan pan di fɔs drɔgs dɛn we dɛn bin fɛn fɔ mɛn kansa. Dɛn stil de yuz dɛn bɔku bɔku wan tide.

Fɔ tɔk am simpul wan, dis kayn mɛrɛsin de wok bay we i de stɔp di kansa sɛl dɛn fɔ mek kɔpi fɔ dɛnsɛf, dat na fɔ mek dɛn nɔ sheb ɛn gro. I de du dis bay we:

εvri sεl gεt di komplit blueprint, כ "blueprint," fכ da sεl de. Wi de kɔl dis DNA. wetin di alkylating ejen dεm de du na fכ go dayrekt to di DNA fכ di kεnsar sεl εn atak dεm. Jɔs lɛk aw wan ki nɔ kin wok if yu stik am to ɔda wan, we dis drɔg tay pan di DNA, da sɛl de nɔ kin ebul fɔ sheb.

We di divεlכpmεnt fכ di sεl dεm stכp dis we, di kεnsar sεl dεm de day sכmtεm. Insay mɛrɛsin, wi kin kɔl dis prɔses apoptosis . Dat min se, we dɛn dɔn program fɔ mek di sɛl dɛn day.

Wan ɔda tin we dɛn drɔgs ya spɛshal na dat dɛn kin atak ɛn pwɛl wan kansa sɛl ɛni stej na in layf saykl. dis dεn kכl am `sεl-saykl fεz nכn spεsifi k`. So, dɛn kin rili ɛp fɔ fɛt bɔku kayn kansa, mɔ di wan dɛn we kin gro kwik kwik wan.

Dɛn kin gi yu dis mɛrɛsin as pil ɔ as salin sɔlvushɔn tru wan vein (IV - intravenous). Bɔku tɛm, yu dɔktɔ go gi yu dis mɛrɛsin wit ɔda kemotɛrapi mɛrɛsin (kɔmbayn tɛrapi).

Wetin na di kayn Alkylating Agents?

Dɛn sheb dis grup fɔ drɔgs to sɔm men grup dɛn. Pan ɔl we di nem fɔ dɛn tin ya kɔmplikt smɔl, i fayn fɔ no bikɔs yu go si wan pan dɛn tin ya we dɛn rayt na yu mɛrɛsin pepa.

Us kayn dɛn kin yuse fɔ gɛt bɔdi kansa?

Drug dεm we de insay di kεtכgεri dεm we na ` Naytrojen Mכstad` εn `Ethylenamine εn methylenamine derivatives` dεn kin yus fכ trit difrεn stej dεm fכ brεst kεnsar.

Saytoksan (Sayklɔfosfamid) .

Dis na drɔg we de pan di `Nitrogen mustard` grup. Yu kin tek am as pil ɔ gi am as IV insay wan vein. Dɛn kin yuz am fɔ:

• Fɔ mek di kansa we dɔn bigin fɔ kam bak afta dɛn dɔn du di ɔpreshɔn.
• If di kansa dɔn go bifo, shrink di lump bifo yu ɔpreshɔn.
• Trit kansa we dɔn go bifo afta dɛn dɔn du ɔpreshɔn ɛn ɔda tritmɛnt dɛn.

Tiotepa we de na di wɔl

Dis na wan dεrivεt fכ `Ethylenamine`. Bɔku tɛm, dɛn kin gi am insay di bɛlɛ. Dɛn kin yuz am fɔ:

• We kansa de bigin, ridyus di risk fɔ mek i gɛt am bak .
• Trit kansa we dɔn go bifo.

Kaboplatin we dɛn kɔl

Dis na drɔg we gɛt platina. Na di wan ol platina drɔg we dɛn dɔn gri fɔ fɔ mɛn bɔdi kansa. `Carboplatin` dεn kin gi am fכ advans kεnsar, εn in kכmbaynshכn wit כda kεmothεrapi dεm. Dɛn kin gi am bak as IV.

Wetin na di bad tin dɛn we dis mɛrɛsin kin du?

Wan pan di men prɔblɛm dɛn we kin mit di kemotɛrapi na dat i nɔ kin ebul fɔ no di difrɛns bitwin di kansa sɛl dɛn ɛn di sɛl dɛn we gɛt wɛlbɔdi. Dɛn drɔgs ya de tɔch di sɛl dɛn we de sheb kwik kwik wan. di kansa sel dεm, lεk sכm hεlty sεl dεm na wi bכdi (fכ egzampl, di sεl dεm we de mek wi ia fכlikul dεm, di sεl dεm we de layn di layn na wi mכt εn intestin, εn blכd sεl dεm), de sheb kwik kwik wan. So dɛn drɔgs ya kin afɛkt dɛn wɛlbɔdi sɛl dɛn de bak, na dat mek dɛn kin gɛt sayd ɛfɛkt.

Dɛn sayd ɛfɛkt ya nɔ kin apin to ɔlman di sem we. Sɔm pipul dɛn kin gɛt mɔ, sɔm kin gɛt smɔl. Nɔ wɔri bɔt dis. Yu dɔktɔ kin ɛp yu fɔ kɔntrol bɔku pan dɛn tin ya.

Na smɔl tɛm nɔmɔ, dɛn alkylating agents ya kin pwɛl wi bon mɛro. Di bon mכro na di say we wi bכdi de mek nyu bכdi sεl dεm. Na smɔl risk de fɔ gɛt ɔda kayn kansa, lɛk lukimiya, bikɔs ɔf dis damej. Dis risk kin go ɔp smɔl as di doz fɔ di mɛrɛsin de go ɔp. Nɔ wɔri bɔt dis we yu nɔ nid fɔ wɔri.Bifo yu bigin fɔ trit yu, tɔk to yu dɔktɔ opin wan bɔt aw fɔ ridyus di risk fɔ gɛt sɛkɔn kansa lɛk dis. I go gi yu ɔl di advays dɛn we yu nid.

Ɔda tin dɛn we yu fɔ tink bɔt we yu de du tritmɛnt

Bikɔs dɛn mɛrɛsin ya na pawaful mɛrɛsin, i impɔtant fɔ tɛl yu dɔktɔ yu kɔmplit mɛdikal istri so dat i go ebul fɔ tayla wan tritmɛnt plan fɔ fit yu ɛn fɔ mek yu nɔ gɛt bɔku sayd ɛfɛkt dɛn. Mek shɔ se yu tɔk to yu dɔktɔ bɔt dɛn tin ya:

• Bɔt ɛni alɛji we yu gɛt (to mɛrɛsin, it).
• Bɔt ɛni vaytamɛn, sɔpɔtmɛnt, ɔ ɛbul mɛrɛsin we yu de yuz.
• Bɔt yu kidni ɔ liva kɔndishɔn.
• If yu dɔn gɛt kemotɛrapi tritmɛnt bifo, tɛl wi bɔt am.
• If yu gɛt bɛlɛ, yu de gi pikin in bɛlɛ, ɔ yu plan fɔ bɔn pikin jisnɔ .
• If yu gɛt ɛni ɔpreshɔn fɔ du tumara bambay, tɔk bɔt am.